Saif MW. U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer. JOP. J Pancreas (Online) [Internet]. 2013 Nov. 10 [cited 2025 May 3];14(6):686-8. Available from: https://serena.sharepress.it/index.php/jop/article/view/2028